U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
178651178651Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal CarcinomatosisCompletedNo Results AvailableIntestinal Obstruction|Carcinoma|Peritoneal NeoplasmsDrug: Lanreotide (microparticle formulation)|Other: Placebohttps://ClinicalTrials.gov/show/NCT00216372
178652178652Cohort Study for Patients Using Fuzeon (Enfuvirtide)Active, not recruitingNo Results AvailableHIV Infections|Antiretroviral TreatmentDrug: Fuzeon (Enfuvirtide)|Procedure: Laboratory diagnostic (CD4-cells)|Procedure: Laboratory diagnostics (HIV-1 viral load)|Drug: antiretroviral co-medication beside Fuzeonhttps://ClinicalTrials.gov/show/NCT00216359
178653178653Safety and Efficacy Study of Paromomycin to Treat Visceral LeishmaniasisCompletedNo Results AvailableVisceral LeishmaniasisDrug: Paromomycin sulfate|Drug: Amphotericin Bhttps://ClinicalTrials.gov/show/NCT00216346
178654178654Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary TuberculosisRecruitingNo Results AvailableTuberculosisDrug: combined fixed dose combinationhttps://ClinicalTrials.gov/show/NCT00216333
178655178655Efficacy of the WalkAide and AFOs for CVACompletedHas ResultsStrokeDevice: WalkAide|Device: AFO|Device: AFOhttps://ClinicalTrials.gov/show/NCT00216320
178656178656Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive DisorderCompletedNo Results AvailableObsessive Compulsive Disorder (OCD)Drug: RG1068 (Synthetic Human Secretin)https://ClinicalTrials.gov/show/NCT00216294
178657178657Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant SchizophreniaTerminatedNo Results AvailableSchizophreniaDrug: Clozapine augmented with atomoxetine up to 40 mg or placebohttps://ClinicalTrials.gov/show/NCT00216281
178658178658Treatment of Japanese EncephalitisRecruitingNo Results AvailableJapanese EncephalitisDrug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00216268
178659178659EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering StudyCompletedNo Results AvailablePersistent Developmental StutteringDrug: Pagoclone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00216255
178660178660Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.Active, not recruitingNo Results AvailableInfluenzaBiological: Influenza virus vaccine (Fluviral)|Biological: Saline placebohttps://ClinicalTrials.gov/show/NCT00216242
178661178661Twinrix Alternative Schedule StudyActive, not recruitingNo Results AvailableAntibody Response After VaccinationBiological: Combined vaccine against hepatitis A and B (Twinrix)https://ClinicalTrials.gov/show/NCT00216229
178662178662Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung CancerTerminatedNo Results AvailableSmall Cell Lung CancerDrug: Pemetrexedhttps://ClinicalTrials.gov/show/NCT00216216
178663178663Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: Pemetrexed|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00216203
178664178664A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous SedationCompletedNo Results AvailableMechanically Ventilated and Intubated SubjectsDrug: Dexmedetomidine HCL Injection|Drug: Midazolam Injectionhttps://ClinicalTrials.gov/show/NCT00216190
178665178665Comparison of Adalimumab and Infliximab Treatment of Rheumatoid ArthritisRecruitingNo Results AvailableRheumatoid ArthritisDrug: Infliximab|Drug: Adalimumabhttps://ClinicalTrials.gov/show/NCT00216177
178666178666Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaTerminatedNo Results AvailableLymphoma, B-CellDrug: Rituximab|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00216164
178667178667Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple MyelomaTerminatedNo Results AvailableMultiple MyelomaDrug: Zoledronic Acidhttps://ClinicalTrials.gov/show/NCT00216151
178668178668Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & NeckTerminatedNo Results AvailableHead and Neck CancerDrug: Docetaxel|Drug: Capecitabine|Drug: Premedicationhttps://ClinicalTrials.gov/show/NCT00216138
178669178669Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: Cisplatin|Drug: Etoposide|Procedure: Radiotherapy|Procedure: Randomize to Further Chemotherapy or Observationhttps://ClinicalTrials.gov/show/NCT00216125
178670178670Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian CancerCompletedNo Results AvailableOvarian CancerDrug: Imatinib Mesylate|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00216112
178671178671Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate CancerCompletedNo Results AvailableProstate CancerDrug: Pemetrexed|Dietary Supplement: Folic Acid|Dietary Supplement: Vitamin B12https://ClinicalTrials.gov/show/NCT00216099
178672178672Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal CancerTerminatedNo Results AvailableRectal CancerDrug: Capecitabine|Drug: Irinotecan|Procedure: EUS|Drug: Neoadjuvant Chemotherapy|Procedure: Preoperative Radiation|Procedure: Surgery|Procedure: Adjuvant Chemotherapyhttps://ClinicalTrials.gov/show/NCT00216086
178673178673Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast CancerTerminatedNo Results AvailableMetastatic Breast CancerDrug: Capecitabine|Drug: Oxaliplatin|Drug: Trastuzumabhttps://ClinicalTrials.gov/show/NCT00216073
178674178674Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal TherapyActive, not recruitingNo Results AvailableMetastatic Prostate CancerDrug: Risedronate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00216060
178675178675PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast CancerTerminatedNo Results AvailableBreast CancerDrug: PTK787|Drug: Trastuzumabhttps://ClinicalTrials.gov/show/NCT00216047
178676178676Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSKActive, not recruitingNo Results AvailableGastric CancerDrug: Tegafur-gimeracil-oteracil potassium (TS-1)|Drug: Krestin (PSK)https://ClinicalTrials.gov/show/NCT00216034
178677178677Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast CancerCompletedNo Results AvailableMetastatic Breast CancerDrug: Capecitabine|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00216021
178678178678Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.TerminatedNo Results AvailableEsophageal Adenocarcinomas|Adenocarcinomas of the Gastroesophageal JunctionDrug: docetaxel|Drug: cisplatin|Procedure: radiation|Procedure: surgeryhttps://ClinicalTrials.gov/show/NCT00216008
178679178679Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasCompletedNo Results AvailableEsophageal Cancer|Gastric CancerDrug: Cisplatin|Drug: Irinotecan|Drug: ZD 1839https://ClinicalTrials.gov/show/NCT00215995
178680178680Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: capecitabine|Drug: Oxaliplatin|Drug: Irinotecanhttps://ClinicalTrials.gov/show/NCT00215982

* Görseller ve İçerik tekif hakkına sahip olabilir